Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles.

Clocks Sleep · 2024 · PMC10968878 · PMID 38534802

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

showed a trendp = 0.20not close (p > 0.1)

Morning treatment ( n = 158) showed a trend toward improved overall survival vs. afternoon ( n = 79); the median survival was 158 vs. 79 days ( p = 0.20, HR = 0.84, CI 95% 0.84–0.91).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.